NurExone Biologic Inc (TSXV:NRX) Stock News, Headlines & Updates
NurExone Biologic Inc Stock News from GuruFocus
- 1
Aug 23, 2024
NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences
Marketwired • 4:00pm
Aug 15, 2024
NurExone Biologic Achieves Key Milestone in Support of Robust Exosome Manufacturing Process
Marketwired • 4:00pm
Aug 09, 2024
NurExone's ExoPTEN, loaded with siRNA, Demonstrates Ability to Target Injury and Inflammation Sites -- New Study
Marketwired • 4:00pm
Aug 01, 2024
NurExone Announces the Transfer of Manufacturing of the Active Element in ExoPTEN Drug to a Commercial GMP Manufacturer
Marketwired • 4:00pm
Jul 29, 2024
NurExone Announces Further Expansion of ExoPTEN Patent Coverage
Marketwired • 4:00pm
Jul 17, 2024
Promising Preliminary Results in Optic Nerve Recovery Study of NurExone's first product ExoPTEN for Glaucoma
Marketwired • 4:00pm
Jul 05, 2024
Updates from NurExone: Growth Conference Presentation and Website Relaunch
Marketwired • 8:00am
Jun 28, 2024
NurExone's ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
Marketwired • 4:00pm
Jun 21, 2024
On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
Marketwired • 4:00pm
Jun 11, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news